X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (592) 592
Book Review (60) 60
Publication (35) 35
Conference Proceeding (18) 18
Book Chapter (9) 9
Book / eBook (4) 4
Reference (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (289) 289
index medicus (287) 287
hypertension (188) 188
peripheral vascular disease (183) 183
male (173) 173
female (172) 172
middle aged (120) 120
blood pressure (119) 119
aged (100) 100
risk factors (100) 100
adult (98) 98
hypertension - drug therapy (78) 78
antihypertensive agents - therapeutic use (70) 70
hypertension - physiopathology (67) 67
prevalence (64) 64
hypertension - complications (58) 58
cardiovascular risk (54) 54
blood-pressure (51) 51
hypertension - diagnosis (51) 51
adolescent (48) 48
mortality (48) 48
obesity (48) 48
diabetes (44) 44
disease (44) 44
guidelines (44) 44
medical and health sciences (43) 43
medicin och hälsovetenskap (43) 43
cross-sectional studies (41) 41
blood pressure - drug effects (40) 40
blood pressure monitoring, ambulatory (40) 40
cardiac & cardiovascular systems (39) 39
children (38) 38
blood pressure - physiology (37) 37
clinical medicine (36) 36
hypertension - epidemiology (36) 36
risk (36) 36
child (35) 35
klinisk medicin (33) 33
medicine, general & internal (33) 33
population (33) 33
adolescents (32) 32
microalbuminuria (32) 32
aged, 80 and over (31) 31
antihypertensive treatment (31) 31
oxidative stress (31) 31
spain - epidemiology (31) 31
left-ventricular hypertrophy (30) 30
prevention (30) 30
prognosis (30) 30
risk assessment (28) 28
cardiovascular diseases (27) 27
spain (27) 27
treatment outcome (27) 27
body mass index (26) 26
coronary-heart-disease (26) 26
young adult (26) 26
cardiovascular disease (25) 25
europe (25) 25
management (24) 24
stroke (24) 24
ambulatory blood pressure (23) 23
internal medicine (23) 23
ambulatory blood-pressure (22) 22
cardiac and cardiovascular systems (22) 22
cardiovascular (22) 22
cardiovascular events (22) 22
hypertension - therapy (22) 22
kardiologi (22) 22
metabolic syndrome (22) 22
albuminuria - etiology (21) 21
association (21) 21
cardiovascular diseases - epidemiology (21) 21
cardiovascular-disease (21) 21
medicine & public health (21) 21
practice guidelines as topic (21) 21
organ damage (20) 20
prospective studies (20) 20
risk-factors (20) 20
analysis (19) 19
circadian rhythm (19) 19
hypertension - genetics (19) 19
societies, medical (19) 19
age factors (18) 18
all-cause mortality (18) 18
ambulatory blood pressure monitoring (18) 18
blood pressure measurement (18) 18
cardiovascular risk-factors (18) 18
research (18) 18
cardiovascular diseases - etiology (17) 17
chronic kidney-disease (17) 17
diabetes mellitus (17) 17
follow-up studies (17) 17
insulin-resistance (17) 17
target organ damage (17) 17
blood pressure determination (16) 16
blood pressure determination - methods (16) 16
body-mass index (16) 16
cardiovascular diseases - prevention & control (16) 16
device therapy (16) 16
drug therapy, combination (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pensamiento. Revista de Investigación e Información Filosófica, ISSN 0031-4749, 05/2014, Volume 70, Issue 262
Journal Article
1999, 1. ed., Columna, ISBN 9788483008140, Volume 339, 153
Book
Nature Reviews Cardiology, ISSN 1759-5002, 04/2017, Volume 14, Issue 4, pp. 193 - 194
Journal Article
1998, 1. ed., Col·lecció d'assaig Argent viu, ISBN 8479354917, Volume 31, 245
Book
1999, 1. ed., Biblioteca universal Empúries, ISBN 8475966330, Volume 123, 170
Book
Journal of Hypertension, ISSN 0263-6352, 09/2016, Volume 34 Suppl 1 - ISH 2016 Abstract Book, pp. e192 - e192
The ESH-ESC Guidelines published in 2007 stated that “Further emphasis has been given to identification of target organ damage, since hypertension-related... 
Journal Article
1997, 1. ed., Biblioteca universal Empúries, ISBN 8475965369, Volume 97, 219
Book
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10085, pp. 2226 - 2237
Summary Background Studies have challenged the appropriateness of accepted blood pressure targets. We hypothesised that different levels of low blood pressure... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ONGOING TELMISARTAN | METAANALYSIS | RAMIPRIL | RATIONALE | DISEASE | GUIDELINES | TARGETS | COMBINATION | HYPERTENSIVE PATIENTS | ANTIHYPERTENSIVE TREATMENT | Benzoates - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Randomized Controlled Trials as Topic - methods | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Hospitalization - statistics & numerical data | Hypertension - drug therapy | Male | Multicenter Studies as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypotension - mortality | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Cardiovascular Diseases - physiopathology | Antihypertensive Agents - therapeutic use | Hypotension - chemically induced | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Telmisartan | Hypotension - complications | Aged | Blood pressure | Hospitals | Research institutes | Germany | Myocardial infarction | Heart | Intervention | Syngeneic grafts | Funding | Medical services | Clinical trials | Cardiovascular disease | Blood | Optimization | Risk factors | Clinical outcomes | Incidence | Recruitment | Peptidyl-dipeptidase A | Risk assessment | Failure analysis | Pretreatment | Heart diseases | Hypertension | Cerebral infarction | Stroke | Risk groups | Adjustment | Categories | Mortality | Regression analysis | Patients | Variance analysis | Oral cavity | Inhibitors | Converting | Angiotensin | Death | Fatalities | Infarction | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hypertension, ISSN 0263-6352, 10/2016, Volume 34, Issue 10, p. 2102
Journal Article
Journal of Hypertension, ISSN 0263-6352, 10/2016, Volume 34, Issue 10, pp. 2102 - 2102
Journal Article
NATURE REVIEWS CARDIOLOGY, ISSN 1759-5002, 04/2017, Volume 14, Issue 4, pp. 193 - 194
Journal Article
Journal of Hypertension, ISSN 0263-6352, 2016, Volume 34, Issue 10, p. 2102
Journal Article
Revista española de cardiología (English ed.), ISSN 0300-8932, 2014, Volume 67, Issue 4, pp. 251 - 253
Journal Article
Journal of Hypertension, ISSN 0263-6352, 04/2015, Volume 33, Issue 4, pp. 698 - 699
Journal Article
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 06/2016, Volume 23, Issue 2, p. 87
Global cardiovascular (CV) risk assessment tries to answer the questions: who will benefit from intervention? And when should non-pharmacologic and... 
Predictive Value of Tests | Prognosis | Age Factors | Risk Assessment | Comorbidity | Humans | Risk Factors | Cardiovascular Diseases - therapy | Decision Support Techniques | Patient Selection | Sex Factors | Cardiovascular Diseases - mortality | Cardiovascular Diseases - diagnosis
Journal Article
High Blood Pressure and Cardiovascular Prevention, ISSN 1120-9879, 07/2015, Volume 22, pp. 3 - 4
Journal Article
High Blood Pressure & Cardiovascular Prevention, ISSN 1120-9879, 7/2015, Volume 22, Issue S1, pp. 3 - 4
Journal Article
High Blood Pressure & Cardiovascular Prevention, ISSN 1120-9879, 07/2015, Volume 22, Issue 1, p. S3
Journal Article
by Hernandez, Adrian F and Green, Fiona and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Michael and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Rosenberg, Anne and Sigmon, Kristina and Sigmon, Kristina N and Somerville, Matthew and Somerville, Matthew C and Thorpe, Karl and Thorpe, Karl M and McMurray, John J V and McMurray, John J.V and Del Prato, Stefano and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Patel, Rajesh and Patel, Vickas and Patel, Prashant and Patel, Rajivkumar and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Harrison, Lindsay and Lopes, Renato and Mathews, Robin and Mehta, Anand and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Deb and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, John and Cooper, Lauren and Sharma, Abhinav and Sharma, Richa and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Wilson, Tim and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and James, Rachel and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Johnson, David and Johnson, Andrew and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Judith and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and ... and Harmony Outcomes Comm Investigator and Harmony Outcomes committees and investigators
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.